Standard Biotools reported $20.1M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Danaher USD 6.55B 254M Sep/2026
Illumina USD 1.17B 10M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
Nikon Corporation JPY 170.48B 6.3B Sep/2026
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Revvity USD 729M 680K Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sony JPY 3.43T 589.45B Sep/2026
Standard Biotools USD 20.1M 996K Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Waters USD 1.77B 130M Sep/2026